2m 2m 2m 2m 2m 2m 2m
GSK Sp ADR (GSK)
NYSE
$51.84+$1.10 (+2.16%)
Price as of Jun 23, 2026 12:43 PM EDT- $101.7BMarket Cap
- 37.62%1-Year Change
- Drug Manufacturers - GeneralIndustry
GSK Sp ADR (GSK)
$51.84+$1.10 (+2.16%)
Earnings Score
Valuation | GSK | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | -0 | ||
Low Earnings Volatility | N/A |
Momentum Score
Valuation | GSK | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -1.57% | ||
12-Month Momentum | 38.42% | ||
3-Month Risk Adjusted Momentum | -14.41% | ||
12-Month Risk Adjusted Momentum | 149.71% |
True Yield
Valuation | GSK | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | 3.64% | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.82% |
Financial Health Score
Valuation | GSK | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 11 |